(VIANEWS) – Costamare (CMRE), Eagle Bancorp Montana (EBMT), Horizon Therapeutics (HZNP) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Costamare (CMRE)

77% sales growth and 20.67% return on equity

Costamare Inc. owns and charters containerships to liner companies worldwide.

Costamare’s sales growth this year is expected to be 51.2% and a negative 1.2% for next year.

Year-on-year quarterly revenue growth grew by 100.4%, now sitting on 628.86M for the twelve trailing months.

Volume

Today’s last reported volume for Costamare is 1943390 which is 183.48% above its average volume of 685530.

Costamare’s sales growth for the next quarter is 77%. The company’s growth estimates for the present quarter and the next is 200% and 125.5%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.67%.

Volatility

Costamare’s last day, last week, and last month’s current intraday variation average was 6.29%, 2.96%, and 2.04%, respectively.

Costamare’s highest amplitude of average volatility was 4.58% (day), 4.66% (last week), and 4.25% (last month), respectively.

Costamare’s Stock Yearly Top and Bottom Value

Costamare’s stock is valued at $16.06 at 20:22 EST, below its 52-week high of $16.72 and way above its 52-week low of $9.18.

Costamare’s Moving Average

Costamare’s worth is way above its 50-day moving average of $13.33 and way above its 200-day moving average of $12.89.

2. Eagle Bancorp Montana (EBMT)

34.7% sales growth and 9.31% return on equity

Eagle Bancorp Montana, Inc. operates as the bank holding company for Opportunity Bank of Montana that provides various retail banking products and services to small businesses and individuals in Montana.

Eagle Bancorp Montana’s sales growth this year is anticipated to be 31.1% and 11.4% for next year.

Year-on-year quarterly revenue growth declined by 7.5%, now sitting on 93.45M for the twelve trailing months.

Volume

Today’s last reported volume for Eagle Bancorp Montana is 13999 which is 12.75% below its average volume of 16045.

Eagle Bancorp Montana’s sales growth for the next quarter is 34.7%. The company’s growth estimates for the present quarter and the next is a negative 34.6% and 69.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.31%.

Volatility

Eagle Bancorp Montana’s last day, last week, and last month’s current intraday variation average was 1.36%, 0.80%, and 0.75%, respectively.

Eagle Bancorp Montana’s highest amplitude of average volatility was 1.72% (day), 1.24% (last week), and 1.38% (last month), respectively.

Eagle Bancorp Montana’s Stock Yearly Top and Bottom Value

Eagle Bancorp Montana’s stock is valued at $22.30 at 20:22 EST, way under its 52-week high of $25.56 and above its 52-week low of $21.62.

Eagle Bancorp Montana’s Moving Average

Eagle Bancorp Montana’s worth is under its 50-day moving average of $22.75 and below its 200-day moving average of $22.65.

3. Horizon Therapeutics (HZNP)

27.5% sales growth and 16.1% return on equity

Horizon Therapeutics Public Limited Company, a biopharmaceutical company, focuses on researching, developing, and commercializing of medicines that address unmet treatment needs for rare and rheumatic diseases in the United States and internationally.

Horizon Therapeutics’s sales growth this year is anticipated to be 41.2% and 23.5% for next year.

Year-on-year quarterly revenue growth grew by 79.9%, now sitting on 2.56B for the twelve trailing months.

Volume

Today’s last reported volume for Horizon Therapeutics is 1158670 which is 30.6% below its average volume of 1669730.

Horizon Therapeutics’s sales growth for the next quarter is 27.5%. The company’s growth estimates for the present quarter and the next is a negative 11.5% and 10.2%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.1%.

Volatility

Horizon Therapeutics’s last day, last week, and last month’s current intraday variation average was 0.94%, 1.15%, and 1.46%, respectively.

Horizon Therapeutics’s highest amplitude of average volatility was 1.60% (day), 1.99% (last week), and 2.64% (last month), respectively.

Horizon Therapeutics’s Stock Yearly Top and Bottom Value

Horizon Therapeutics’s stock is valued at $108.49 at 20:22 EST, under its 52-week high of $120.54 and way above its 52-week low of $66.41.

Horizon Therapeutics’s Moving Average

Horizon Therapeutics’s worth is under its 50-day moving average of $109.80 and above its 200-day moving average of $100.05.

4. WEX (WEX)

18.8% sales growth and 6.6% return on equity

WEX Inc. provides financial technology services in North America, the Asia Pacific, and Europe.

WEX’s sales growth this year is expected to be 12.6% and 9.5% for next year.

Year-on-year quarterly revenue growth grew by 26.8%, now sitting on 1.85B for the twelve trailing months.

Volume

Today’s last reported volume for WEX is 331107 which is 26.94% below its average volume of 453241.

WEX’s sales growth for the next quarter is 18.8%. The company’s growth estimates for the current quarter and the next is 46.4% and 22.9%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.6%.

Volatility

WEX’s last day, last week, and last month’s current intraday variation average was 0.99%, 2.11%, and 1.98%, respectively.

WEX’s highest amplitude of average volatility was 2.37% (day), 4.24% (last week), and 4.19% (last month), respectively.

WEX’s Stock Yearly Top and Bottom Value

WEX’s stock is valued at $159.56 at 20:22 EST, way below its 52-week high of $232.07 and way above its 52-week low of $123.01.

WEX’s Moving Average

WEX’s worth is higher than its 50-day moving average of $159.06 and below its 200-day moving average of $169.51.

5. First Guaranty Bancshares (FGBI)

17% sales growth and 13.56% return on equity

First Guaranty Bancshares, Inc. operates as the holding company for First Guaranty Bank that provides commercial banking services in Louisiana and Texas.

First Guaranty Bancshares’s sales growth this year is anticipated to be 14.5% and 8.5% for next year.

Year-on-year quarterly revenue growth grew by 18.1%, now sitting on 98.32M for the twelve trailing months.

Volume

Today’s last reported volume for First Guaranty Bancshares is 5334 which is 37.21% below its average volume of 8496.

First Guaranty Bancshares’s sales growth for the next quarter is 17%. The company’s growth estimates for the current quarter and the next is 25.5% and 3.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.56%.

Volatility

First Guaranty Bancshares’s last day, last week, and last month’s current intraday variation average was 2.70%, 3.35%, and 1.80%, respectively.

First Guaranty Bancshares’s highest amplitude of average volatility was 3.94% (day), 5.74% (last week), and 3.36% (last month), respectively.

First Guaranty Bancshares’s Stock Yearly Top and Bottom Value

First Guaranty Bancshares’s stock is valued at $23.37 at 20:22 EST, under its 52-week high of $25.05 and way higher than its 52-week low of $15.01.

First Guaranty Bancshares’s Moving Average

First Guaranty Bancshares’s value is way higher than its 50-day moving average of $21.22 and way above its 200-day moving average of $19.26.

6. SilverSun Technologies (SSNT)

13.2% sales growth and 8.81% return on equity

SilverSun Technologies, Inc. operates as a business application, technology, and consulting company.

SilverSun Technologies’s sales growth this year is expected to be 17.6% and 5.6% for next year.

Year-on-year quarterly revenue growth declined by 0.5%, now sitting on 42.53M for the twelve trailing months.

Volume

Today’s last reported volume for SilverSun Technologies is 2224150 which is 1022.21% above its average volume of 198194.

SilverSun Technologies’s sales growth for the next quarter is 13.2%. The company’s growth estimates for the present quarter and the next is a negative 0% and negative 0%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.81%.

Volatility

SilverSun Technologies’s last day, last week, and last month’s current intraday variation average was 34.16%, 10.12%, and 4.90%, respectively.

SilverSun Technologies’s highest amplitude of average volatility was 43.47% (day), 15.23% (last week), and 11.36% (last month), respectively.

SilverSun Technologies’s Stock Yearly Top and Bottom Value

SilverSun Technologies’s stock is valued at $4.32 at 20:22 EST, way below its 52-week high of $14.87 and way above its 52-week low of $2.95.

SilverSun Technologies’s Moving Average

SilverSun Technologies’s worth is way higher than its 50-day moving average of $3.74 and way below its 200-day moving average of $6.32.

7. The Cheesecake Factory Incorporated (CAKE)

7.4% sales growth and 17.29% return on equity

The Cheesecake Factory Incorporated operates restaurants.

The Cheesecake Factory Incorporated’s sales growth this year is expected to be 13.9% and 5% for next year.

Year-on-year quarterly revenue growth grew by 40.1%, now sitting on 2.93B for the twelve trailing months.

Volume

Today’s last reported volume for The Cheesecake Factory Incorporated is 892285 which is 7.17% below its average volume of 961285.

The Cheesecake Factory Incorporated’s sales growth for the next quarter is 7.4%. The company’s growth estimates for the present quarter and the next is 155% and 3.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.29%.

Volatility

The Cheesecake Factory Incorporated’s last day, last week, and last month’s current intraday variation average was 1.76%, 2.90%, and 3.47%, respectively.

The Cheesecake Factory Incorporated’s highest amplitude of average volatility was 4.50% (day), 4.95% (last week), and 5.85% (last month), respectively.

The Cheesecake Factory Incorporated’s Stock Yearly Top and Bottom Value

The Cheesecake Factory Incorporated’s stock is valued at $35.86 at 20:22 EST, way under its 52-week high of $65.81 and way higher than its 52-week low of $31.43.

The Cheesecake Factory Incorporated’s Moving Average

The Cheesecake Factory Incorporated’s value is below its 50-day moving average of $38.20 and way under its 200-day moving average of $44.28.

LEAVE A REPLY

Please enter your comment!
Please enter your name here